| |
| |
| Exchange: |
|
| Security
Type: |
|
| Shares
Out: |
34,810,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
|
| Level
II Sector: |
|
| Level
III Sector: |
|
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile COMPASS Pathways is a mental health care company focusing on accelerating patient access to evidence-based innovation in mental health. Co. is developing psilocybin therapy through late-stage clinical trials for patients with treatment-resistant depression. Co. has developed a high-purity polymorphic crystalline formulation of psilocybin, COMP360. COMP360 is Co.'s psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. Co.'s investigational COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from trained therapists with specific persibbel and educational qualifications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
708,736 |
1,270,104 |
1,270,104 |
1,270,104 |
| Total Sell Value |
$6,619,930 |
$11,750,108 |
$11,750,108 |
$11,750,108 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
40 |
72 |
72 |
72 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Goldsmith George Jay |
Director |
– • • |
2023-12-13 |
4 |
AS |
$7.82 |
$22,320 |
I/I |
(2,855) |
4,264,586 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-12-13 |
4 |
AS |
$7.82 |
$22,320 |
D/D |
(2,855) |
4,267,244 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-11-01 |
4 |
D |
$5.78 |
$8,820 |
I/I |
(1,526) |
4,267,441 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-11-01 |
4 |
D |
$5.78 |
$8,497 |
D/D |
(1,470) |
4,270,099 |
|
- |
|
| Malievskaia Ekaterina |
Director |
– • • |
2023-11-01 |
4 |
D |
$5.78 |
$8,497 |
I/I |
(1,470) |
4,270,099 |
|
- |
|
| Malievskaia Ekaterina |
Director |
– • • |
2023-11-01 |
4 |
D |
$5.78 |
$8,820 |
D/D |
(1,526) |
4,267,441 |
|
- |
|
| Jenkins Annalisa |
Director |
– • – |
2023-11-01 |
4 |
D |
$5.78 |
$827 |
D/D |
(143) |
20,027 |
|
- |
|
| Hughes Mary-Rose |
Interim CFOOfficer |
• – – |
2023-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,232 |
|
- |
|
| Nath Kabir |
Chief Executive Officer |
• • – |
2023-08-01 |
4/A |
D |
$8.95 |
$51,856 |
D/D |
(5,794) |
69,406 |
|
- |
|
| Jenkins Annalisa |
Director |
– • – |
2023-08-01 |
4 |
D |
$8.95 |
$1,441 |
D/D |
(161) |
20,170 |
|
- |
|
| Nath Kabir |
Chief Executive Officer |
• • – |
2023-08-01 |
4 |
D |
$8.95 |
$44,750 |
D/D |
(5,000) |
70,200 |
|
- |
|
| Malievskaia Ekaterina |
Director |
– • • |
2023-08-01 |
4 |
D |
$8.95 |
$13,157 |
I/I |
(1,470) |
4,271,569 |
|
- |
|
| Malievskaia Ekaterina |
Director |
– • • |
2023-08-01 |
4 |
D |
$8.95 |
$13,658 |
D/D |
(1,526) |
4,268,967 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-08-01 |
4 |
D |
$8.95 |
$13,658 |
I/I |
(1,526) |
4,268,967 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-08-01 |
4 |
D |
$8.95 |
$13,157 |
D/D |
(1,470) |
4,271,569 |
|
- |
|
| Malievskaia Ekaterina |
Chief Innovation Officer |
• • • |
2023-05-02 |
4 |
D |
$7.97 |
$11,716 |
I/I |
(1,470) |
4,273,039 |
|
- |
|
| Malievskaia Ekaterina |
Chief Innovation Officer |
• • • |
2023-05-02 |
4 |
D |
$7.97 |
$12,162 |
D/D |
(1,526) |
4,270,493 |
|
- |
|
| Jenkins Annalisa |
Director |
– • – |
2023-05-02 |
4 |
D |
$7.97 |
$199 |
D/D |
(25) |
20,331 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-05-02 |
4 |
D |
$7.97 |
$12,162 |
I/I |
(1,526) |
4,270,493 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-05-02 |
4 |
D |
$7.97 |
$11,716 |
D/D |
(1,470) |
4,273,039 |
|
- |
|
| Malievskaia Ekaterina |
Chief Innovation Officer |
• • • |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,700 |
4,272,019 |
|
- |
|
| Nath Kabir |
Chief Executive Officer |
• • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,200 |
75,200 |
|
- |
|
| Falvey Michael |
Chief Financial Officer |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
22,500 |
|
- |
|
| Goldsmith George Jay |
Director |
– • • |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
I/I |
11,700 |
4,272,019 |
|
- |
|
| Owens Matthew A |
General Counsel & CLO |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,800 |
21,507 |
|
- |
|
130 Records found
|
|
Page 4 of 6 |
|
|
